EA200970807A1 - Модуляция подвижности сперматозоидов - Google Patents

Модуляция подвижности сперматозоидов

Info

Publication number
EA200970807A1
EA200970807A1 EA200970807A EA200970807A EA200970807A1 EA 200970807 A1 EA200970807 A1 EA 200970807A1 EA 200970807 A EA200970807 A EA 200970807A EA 200970807 A EA200970807 A EA 200970807A EA 200970807 A1 EA200970807 A1 EA 200970807A1
Authority
EA
Eurasian Patent Office
Prior art keywords
spermatosis
mobility
modulation
sperm
methods
Prior art date
Application number
EA200970807A
Other languages
English (en)
Inventor
Гульельмо Бонанни
Марко Россато
Франческо Ди Вирджилио
Original Assignee
Дуска Сайнтифик Ко.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дуска Сайнтифик Ко. filed Critical Дуска Сайнтифик Ко.
Publication of EA200970807A1 publication Critical patent/EA200970807A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)

Abstract

Предложены способы повышения фертильности сперматозоидов млекопитающих, предусматривающие контакт сперматозоидов с аденозин-5'-трифосфатом, и способы оплодотворения с использованием сперматозоидов, обработанных указанным образом.
EA200970807A 2007-02-27 2008-02-27 Модуляция подвижности сперматозоидов EA200970807A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89183607P 2007-02-27 2007-02-27
PCT/US2008/055153 WO2008106527A2 (en) 2007-02-27 2008-02-27 Modulation of sperm motility

Publications (1)

Publication Number Publication Date
EA200970807A1 true EA200970807A1 (ru) 2010-06-30

Family

ID=39721832

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970807A EA200970807A1 (ru) 2007-02-27 2008-02-27 Модуляция подвижности сперматозоидов

Country Status (12)

Country Link
US (1) US20100222293A1 (ru)
EP (1) EP2115457A2 (ru)
JP (1) JP2010518876A (ru)
KR (1) KR20100018488A (ru)
CN (1) CN101688859A (ru)
AU (1) AU2008221449A1 (ru)
BR (1) BRPI0808149A2 (ru)
CA (1) CA2679390A1 (ru)
EA (1) EA200970807A1 (ru)
IL (1) IL200609A0 (ru)
MX (1) MX2009009262A (ru)
WO (1) WO2008106527A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100222294A1 (en) * 2009-02-27 2010-09-02 Duska Scientific Co. Formulations of ATP and Analogs of ATP
CN107988149A (zh) * 2017-11-22 2018-05-04 瑞柏生物（中国）股份有限公司 一种精子活力液及其制备方法
KR102247376B1 (ko) 2019-07-31 2021-05-03 주식회사 엠케이바이오텍 흑삼 분말을 포함하는 개과 동물의 정자 운동성 증가용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU666011B2 (en) * 1992-04-09 1996-01-25 Francesco Di Virgilio Method for inducing the acrosome reaction in human and animal spermatozoa

Also Published As

Publication number Publication date
AU2008221449A1 (en) 2008-09-04
EP2115457A2 (en) 2009-11-11
IL200609A0 (en) 2010-05-17
CA2679390A1 (en) 2008-09-04
BRPI0808149A2 (pt) 2016-11-08
CN101688859A (zh) 2010-03-31
MX2009009262A (es) 2010-06-01
WO2008106527A2 (en) 2008-09-04
US20100222293A1 (en) 2010-09-02
KR20100018488A (ko) 2010-02-17
JP2010518876A (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
MY160041A (en) Compositions and methods for treating parasitic infections
IS6667A (is) Aðferðir til að meðhöndla gigtarsjúkdóma með því að nota leysanlega CTLA4 sameind
HN2005029978A (es) Formulaciones
AR057614A1 (es) Composiciones y metodos para producir moleculas de union con antigeno hibridas y usos de las mismas
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
CL2007003622A1 (es) Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
IN2012DN02452A (ru)
AR069860A1 (es) Metodo para purificar un anticuerpo cd20
ATE481092T1 (de) Verfahren und zusammensetzungen zur apoptoseinduktion in krebszellen
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
ATE387890T1 (de) Winkelstabile vorrichtung zur gegenseitigen fixierung eines longitudinalen längsträgers mit einem knochenfixationselement
ZA200606620B (en) Methods of modulating IL-23 activity ; related reagents
WO2006052646A3 (en) Derivation of embryonic stem cells
CL2007003649A1 (es) Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70.
GT200600407A (es) Compuestos ppar activos
DK1771474T3 (da) Inhibitorer af angiopoitin-like 4 protein, kombinationer og anvendelser deraf
SG166788A1 (en) Use of b cell expansion agents in generating antibodies
TW200633948A (en) Composites and methods for the manufacture and use thereof
BRPI0606370A2 (pt) tratamento dos distúrbios de hcv
EA200970884A1 (ru) Способы лечения рака путем введения комбинаций человеческого интерлейкина ил-18
BRPI0820915A8 (pt) Método para expandir células-tronco hematopoéticas usando composto heterocíclico
AR051763A1 (es) Tratamiento de mastitis
EA200970807A1 (ru) Модуляция подвижности сперматозоидов
IN2012DN03844A (ru)